running title: Ras signaling in muscle development key words: myogenesis, signal integration, founder cell, muscle progenitor, fusion competent myoblast 2 1 SUMMARY 2 A fundamentally different mechanism is shown for how Ras signaling governs cell fate 3 specification in the Drosophila somatic versus visceral mesoderms, providing insight into how 4 signaling specificity is achieved.
INTRODUCTION
activation of the Ras pathway, the expanded reporter gene expression extends throughout the (construct "mib2_FC626 ETS ; Fig. 4E, F, G) . In contrast, a more extensive 5' 413 bp deletion (Fig. 149 4B arrowhead, Fig. S2 , gray arrow) leads to a complete loss of visceral mesoderm activity and 150 only a limited residual expression elsewhere (data not shown). As the mib2_FC626 enhancer 151 behaves in all aspects like the original mib2_FCenhancer, we used this shorter sequence as a 152 template for further characterization of mib2 regulation. 153 We mutated the six remaining ETS-type sequences individually to determine which putative 154 binding sites were responsible for the expanded reporter gene expression (as sites 5 and 6 are 155 close together, we treated them initially as a single site5-6). Expanded reporter gene expression 156 was observed only with the site5-6 paired mutation ( Fig. 4J, Fig. S3 ). We therefore further 157 dissected this pair to test its component individual sites. Mutation of site 5 led to expansion of 158 mib2_FC626 enhancer activity throughout the visceral mesoderm ( Fig. 4K ), while site 6 by itself 159 had a barely observable phenotype with expanded expression almost indistinguishable from 160 background (Fig. S1G) . The expanded expression observed with the single site 5 mutation was 161 notably weaker than that observed with the paired site5-6 mutation, which itself had weaker 162 expression than the mib2_FC626 ETS six-site-mutated enhancer (Compare Fig. 4G , J, and K). 163 While site 5 therefore appears to be the most critical site contributing to expanded mib2_FC626 164 expression, the stronger expression seen when multiple sites are mutated suggests that these 165 other sites are functional as well and contribute to overall enhancer activity. Consistent with their 166 more essential roles, site 5 is the most highly conserved of the six ETS sites in the mib2_FC626 167 sequence, followed by site 6 (Fig. S2B) . 168 In addition to expanded visceral mesoderm expression, the mib2_FC626 ETS construct drives 169 ectopic reporter gene expression in the midline of the ventral nerve cord (Fig. 4M-O and Halfon et al., 2011) . This ectopic midline expression is also observed with the mib2_FC626 site7 construct 171 ( Fig. 4L ), but not with any of the other single-site enhancer mutations. Similar ectopic mib2 172 expression is observed in aop null mutant embryos ( Fig. 4P ), suggesting that while Aop does not 173 regulate mib2 in the visceral mesoderm, it may act via this site to repress mib2 in the nervous 174 system.
176
The de-repressed mib2 enhancer does not require Ras pathway signaling for its activity 177 In the somatic mesoderm, we showed previously that Ras pathway activity is absolutely required 178 for FC gene expression; for example, in the absence of both pnt and aop expression the 179 eve_MHE FC enhancer is inactive, and mutation of the common ETS-type Pnt and Aop binding 180 sites eliminates enhancer activity (Halfon et al., 2000) . However, the de-repression of the mib2 181 visceral FC enhancer seen with ETS site mutation suggested that Ras activity, normally not 182 present in the FCM population into which mib2 reporter gene expression expands, might be 183 dispensable when the mib2 enhancer is de-repressed. To test this, we analyzed the activity of the 184 wild-type and mutated mib2_FC626 enhancers in a jeb null background, which lacks Ras 185 signaling in the visceral mesoderm. Whereas the wild type mib2_FC626 enhancer is inactive in 186 the visceral mesoderm of jeb null embryos ( Fig. 5A ), the mib2_FC626 ETS mutated enhancer is 187 expressed throughout the visceral mesoderm just as in a wild type background ( Fig. 5B, arrows) .
188
Staining for the activated, di-phosphorylated form of MAPK confirmed that no signaling was 189 present in the jeb null background (Fig. 5D ). Unlike in the somatic mesoderm, therefore, Ras null embryos no FC markers are expressed, expression in jeb;lmd embryos consistently 212 resembles lmd alone, in most cases with expanded FC expression ( Fig. 6) . Surprisingly, mib2 and 213 RhoGAP15B, which expand throughout the visceral mesoderm both with Ras activation and 214 upon mutation of the mib2 FC enhancer, do not appear to have expanded expression in the lmd 215 background when assayed by in situ hybridization (Fig. 6B, 6F ). This may be indicative of an 216 incomplete conversion of FCMs to FCs, consistent with the maintenance of sns expression in the 217 FCM region reported previously. Likewise, Wg expression also only expands to a few additional 218 cells and not throughout the entire width of the anterior PS8 visceral mesoderm ( Fig. 6S ). On the 219 other hand, we found that the mib2_FC626 reporter construct does show fully expanded 220 expression in lmd embryos ( Fig. 6B') . As expression driven by the mib2_FC626 enhancer 221 appears identical to endogenous mib2 expression in all other contexts we have examined, it may 222 be that the lack of expanded mib2 expression observed in lmd embryos simply represents a 223 failure of detection, given that, similar to what we saw with the reporter construct in other 224 backgrounds, reporter gene expression in the FCM region is weaker than that in the native FC 225 region ( Fig. S1D ). Consistent with this interpretation, we see a modest widening of mib2 226 expression in the jeb;lmd embryos ( Fig. 6D ). Importantly, regardless of the exact degree of 227 expanded expression due to lmd loss of function, FC expression of all tested genes is clearly 228 rescued in the jeb;lmd background, demonstrating the ability for Ras signaling to be bypassed in 229 the absence of lmd expression.
230
To ensure that the rescue of FC specification observed in jeb;lmd mutants is not the result of a 231 cryptic Ras signaling pathway activated by loss of lmd, we checked for the presence of activated 232 MAPK in the double-mutant embryos. As expected when jeb is absent, no activated MAPK is 233 observed, regardless of presence or absence of lmd (Fig. 6X, Y) .
234

DISCUSSION
236
Both somatic and visceral muscle development require as an initial step the specification of 237 individual muscle founder cells from within the general myoblast pool. Superficially, the process 238 appears alike for both tissues: FCs fail to form in the absence of RTK/Ras/MAPK signaling, and 239 ectopic activation of the Ras pathway causes FCMs to be respecified as FCs. A striking aspect of 240 our current results is that these seemingly similar events are brought about in a mechanistically 241 opposite fashion in the somatic versus visceral mesoderms. Our work therefore serves to 242 underscore how common developmental outcomes can derive from dramatically different gene 243 regulatory mechanisms.
244
In the somatic mesoderm, it has been well-established that positive induction via Ras/MAPK 245 signaling is essential for specifying FC fates (Buff et al., 1998 , Carmena et al., 2002 , Carmena et 246 al., 1998 , Halfon et al., 2000 . In the visceral mesoderm, however, repression has primacy over 247 induction. We demonstrate here that Ras/MAPK signaling acts in presumptive FCs to relieve what happens with Aop at other loci (Rebay and Rubin, 1995) ). This would be consistent with 274 the rapid timecourse of FC fate specification following MAPK activation. We surmise that there 275 are also additional, still unknown FC gene activators whose activity may or may not be MAPK Given the derepression phenotypes observed on mutation of the ETS sites in the mib2 enhancer, 292 we favor the likelihood that the relevant repressor is a member of the ETS transcription factor different FCs are specified at different levels of RTK/Ras signaling. One way to achieve such 317 differential sensitivity would be through a mixture of activating versus repressing ETS 318 transcription factors competing for binding at a range of high-and low-affinity sites. Such a 319 mechanism could provide for exquisitely fine-tuned responsiveness to Ras/MAPK signaling, 320 making this an appealing possibility.
321
In this vein, we note that our detailed molecular insights for visceral FCs again come mainly 323 from the study of a single enhancer, mib2_FC626. Here, elimination of the major ETS binding 324 sites leads to increased activity, opposite the situation with the somatic eve_MHE enhancer. Figure S3 A B D C mib2_FC626 WT mib2_FC626 site2 mib2_FC626 WT mib2_FC626 site3 mib2_FC626 WT mib2_FC626 site4 mib2_FC626 WT mib2_FC626 site7
